↓ Skip to main content

IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology

Overview of attention for article published in Journal of Neuroinflammation, March 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
Published in
Journal of Neuroinflammation, March 2014
DOI 10.1186/1742-2094-11-54
Pubmed ID
Authors

Isabelle St-Amour, Isabelle Paré, Cyntia Tremblay, Katherine Coulombe, Renée Bazin, Frédéric Calon

Abstract

Intravenous immunoglobulin (IVIg) is currently in clinical study for Alzheimer's disease (AD). However, preclinical investigations are required to better understand AD-relevant outcomes of IVIg treatment and develop replacement therapies in case of unsustainable supply.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Unknown 79 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 19%
Student > Master 14 18%
Researcher 13 16%
Student > Bachelor 11 14%
Student > Doctoral Student 6 8%
Other 9 11%
Unknown 12 15%
Readers by discipline Count As %
Neuroscience 14 18%
Agricultural and Biological Sciences 13 16%
Psychology 9 11%
Biochemistry, Genetics and Molecular Biology 8 10%
Medicine and Dentistry 7 9%
Other 8 10%
Unknown 21 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2014.
All research outputs
#18,367,612
of 22,749,166 outputs
Outputs from Journal of Neuroinflammation
#2,057
of 2,617 outputs
Outputs of similar age
#162,062
of 223,665 outputs
Outputs of similar age from Journal of Neuroinflammation
#21
of 30 outputs
Altmetric has tracked 22,749,166 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,617 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 223,665 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.